BioSpace News Archive

MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. Patent and Trademark Office (USPTO) awarded to the company U.S. Patent 11,219,620 B2, titled “Method of Treating Sarcopenia.”

An important public health webinar focused on the Bartonella species, the bacterium that causes Bartonellosis, is now available on demand at https://education.quidel.com/educational-categories.

Barrow Neurological Institute, the world’s largest neurological disease treatment and research institution, in conjunction with Arizona State University, have selected Cubresa’s BrainPET system to add to their suite of imaging tools.

Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has opened a new facility in Fremont, California – tripling its current manufacturing capacity in order to meet growing global demand for cell analysis solutions.

Cantabio Pharmaceuticals, Inc. announced that The Michael J. Fox Foundation for Parkinson’s Research has awarded the Company a major grant for a project entitled “Development of small-molecule inhibitors to reduce the aggregation of tau for the treatment of Parkinson’s disease.”

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the Curian® Campy assay has received U.S. Food and Drug Administration (FDA) clearance.

MingMed Biotechnology today announced that Ms. Liza Ko , Chief Financial Officer of the company, has been invited to present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 10, 2022 at 08:00 AM ET.

Xoran Technologies announces the installation of its 50th VetCAT at Perkins Road Animal Hospital— a major milestone for Xoran and their state-of-the-art, 3D computed tomography imaging solution.

Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak™ report on industry leaders in diagnostic imaging equipment in the United States.

Mirvie, a pioneer in predicting unexpected pregnancy complications, today announced the publication of a study in Nature proving the proprietary Mirvie RNA platform is first to predict unexpected complications by revealing the underlying biology of each pregnancy.